Finance

Lists
Q2 2027 earnings • released • Revenue beat +6.06%
See results
4118:TYO
Kaneka Corp
Â¥6,533.00
+0.74%
(+48.00) 1D
Nov 13, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4118...
Open
Â¥6,507
High
Â¥6,557
Low
Â¥6,423
Mkt. cap
411.58B
Avg. vol.
239.67K
Volume
369.60K
Dividend
2.45%
Quarterly dividend
Â¥40
Ex-dividend date
Mar 30, 2027
P/E ratio
11.20
52-wk high
Â¥6,570
52-wk low
Â¥4,113
EPS
Â¥583
Shares outstanding
65.56M
No. of employees
12K
Open
Â¥6,507
High
Â¥6,557
Low
Â¥6,423
Mkt. cap
411.58B
Avg. vol.
239.67K
Volume
369.60K
Dividend
2.45%
Quarterly dividend
Â¥40
Ex-dividend date
Mar 30, 2027
P/E ratio
11.20
52-wk high
Â¥6,570
52-wk low
Â¥4,113
EPS
Â¥583
Shares outstanding
65.56M
No. of employees
12K
News stories
From web sources and news partners
Profile
Kaneka Corporation is a Japanese international chemical manufacturing company based in Osaka. The company was founded in 1949 and produces chemical products such as functional resin, foam resin, and synthetic fibers. The company was also engaged in the medical equipment business. In recent years, the company manufactured raw material for production of coenzyme Q10, and apheresis devices, where blood of a donor or patient is passed through an apparatus that separates out one particular constituent and returns the remainder to the circulation. Wikipedia
About Kaneka Corp
CEO-
Employees11.8K
FoundedSep 1, 1949
Headquarters-
SectorMaterials
IndustryCommodity chemical
Last report
Nov 11, 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (JPY)
223.95B / 211.15B
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
200.85B
213.36B
223.02B
223.95B
Cost of goods sold
144.80B
152.38B
157.45B
158.21B
Cost of revenue
144.80B
152.38B
157.45B
158.21B
Research and development expenses
-
39.89B
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
48.81B
847.00M
50.64B
52.00B
Operating expense
48.81B
51.54B
50.64B
52.00B
Total operating expenses
193.62B
203.92B
208.08B
210.21B
Operating income
7.23B
9.44B
14.94B
13.73B
Other non operating income
-340.00M
1.29B
-222.00M
-1.88B
EBT including unusual items
11.33B
16.62B
13.42B
8.97B
EBT excluding unusual items
7.98B
10.87B
14.69B
9.63B
Income tax expense
3.58B
3.60B
3.92B
2.68B
Effective tax rate
31.57%
21.67%
29.24%
29.86%
Other operating expenses
-
-
-
-
Net income
7.39B
12.54B
8.94B
5.70B
Net profit margin
3.68%
5.88%
4.01%
2.55%
Earnings per share
-
-
-
-
Interest and investment income
771.00M
385.00M
675.00M
129.00M
Interest expense
-1.00B
-1.07B
-1.09B
-1.24B
Net interest expenses
-229.00M
-682.00M
-419.00M
-1.11B
Depreciation and amortization charges
-
10.80B
-
-
EBITDA
18.22B
21.30B
26.80B
25.59B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps